Northwestern Medicine investigators have discovered new mechanisms underlying cellular adhesion and repair, findings that ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...